Biofilm analyses and exoproduct release by clinical and environmental isolates of Burkholderia pseudomallei from Brazil

被引:0
|
作者
de Melo Guedes, Glaucia Morgana [1 ,3 ]
Ocadaque, Crister Jose [1 ]
Freitas, Alyne Soares [1 ]
Pinheiro, Rodrigo Machado [1 ]
Riello, Giovanna Barbosa [2 ]
Bandeira, Silviane Praciano [3 ]
Cordeiro, Rossana de Aguiar [3 ]
Gadelha Rocha, Marcos Fabio [3 ,4 ]
Costa Sidrim, Jose Julio [3 ]
Collares Maia Castelo-Branco, Debora de Souza [1 ,3 ]
机构
[1] Univ Fed Ceara, Dept Pathol & Legal Med, Grp Appl Med Microbiol, Postgrad Program Med Microbiol, Fortaleza, CE, Brazil
[2] Univ Fed Ceara, Sch Pharm, Dept Clin & Toxicol Anal, Fortaleza, CE, Brazil
[3] Univ Fed Ceara, Dept Pathol & Legal Med, Postgrad Program Med Microbiol, Lab Emerging & Reemerging Pathogens, Fortaleza, CE, Brazil
[4] Univ Estadual Ceara, Sch Vet Med, Postgrad Program Vet Sci, Fortaleza, CE, Brazil
关键词
Mangosteen; Burkholderia pseudomallei; Biofilms; Proteases; Hemolysins; Siderophores; PSEUDOMONAS-AERUGINOSA; QUANTIFICATION; VIRULENCE;
D O I
10.4103/1995-7645.378565
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: To characterize biofilm production by clinical (n=21) and environmental (n=11) isolates of Burkholderia pseudomallei and evaluate the production of proteases, hemolysins and siderophores. Methods: Initially, the 32 strains were evaluated for biofilm production in Muller-Hinton broth-1% glucose (MH-1% glucose) and BHI broth-1% glucose, using the crystal violet staining technique. Subsequently, growing (48 h) and mature (72 h) biofilms were evaluated by confocal microscopy. Finally, the production of proteases, hemolysins and siderophores by planktonic aggregates, growing biofilms and mature biofilms was evaluated. Results: All isolates produced biofilms, but clinical isolates had significantly higher biomass in both MH-1% glucose (P<0.001) and BHI-glucose 1% (P=0.005). The structural analyses by confocal microscopy showed thick biofilms, composed of multiple layers of cells, homogeneously arranged, with mature biofilms of clinical isolates presenting higher biomass (P=0.019) and thickness of the entire area (P=0.029), and lower roughness coefficient (P=0.007) than those of environmental isolates. Protease production by growing biofilms was significantly greater than that of planktonic (P<0.001) and mature biofilms (P<0.001). Hemolysin release by planktonic aggregates was higher than that of biofilms (P<0.001). Regarding siderophores, mature biofilms presented higher production than growing biofilms (P<0.001) and planktonic aggregates (P<0.001). Conclusions: Clinical isolates have higher production of biofilms than their environmental counterparts; protease and siderophores seem important for growth and maintenance of Burkholderia pseudomallei biofilms.
引用
收藏
页码:321 / 328
页数:8
相关论文
共 50 条
  • [31] The BpeEF-OprC Efflux Pump Is Responsible for Widespread Trimethoprim Resistance in Clinical and Environmental Burkholderia pseudomallei Isolates
    Podnecky, Nicole L.
    Wuthiekanun, Vanaporn
    Peacock, Sharon J.
    Schweizer, Herbert P.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (09) : 4381 - 4386
  • [32] Molecular Basis of Rare Aminoglycoside Susceptibility and Pathogenesis of Burkholderia pseudomallei Clinical Isolates from Thailand
    Trunck, Lily A.
    Propst, Katie L.
    Wuthiekanun, Vanaporn
    Tuanyok, Apichai
    Beckstrom-Sternberg, Stephen M.
    Beckstrom-Sternberg, James S.
    Peacock, Sharon J.
    Keim, Paul
    Dow, Steven W.
    Schweizer, Herbert P.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2009, 3 (09):
  • [33] The Burkholderia pseudomallei RpoE (AlgU) operon is involved in environmental stress tolerance and biofilm formation
    Korbsrisate, S
    Vanaporn, M
    Kerdsuk, P
    Kespichayawattana, W
    Vattanaviboon, P
    Kiatpapan, P
    Lertmemongkolchai, G
    [J]. FEMS MICROBIOLOGY LETTERS, 2005, 252 (02) : 243 - 249
  • [34] Burkholderia pseudomallei Clinical Isolates Are Highly Susceptible In Vitro to Cefiderocol, a Siderophore Cephalosporin
    Burnard, Delaney
    Robertson, Gemma
    Henderson, Andrew
    Falconer, Caitlin
    Bauer, Michelle J.
    Cottrell, Kyra
    Gassiep, Ian
    Norton, Robert
    Paterson, David L.
    Harris, Patrick N. A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (02)
  • [35] Whole- genome comparative analysis of Malaysian Burkholderia pseudomallei clinical isolates
    Ghazali, Ahmad-Kamal
    Eng, Su-Anne
    Khoo, Jia-Shiun
    Teoh, Seddon
    Hoh, Chee-Choong
    Nathan, Sheila
    [J]. MICROBIAL GENOMICS, 2021, 7 (02): : 1 - 12
  • [36] Transcriptional landscape of Burkholderia pseudomallei cultured under environmental and clinical conditions
    Kong, Cin
    Wong, Rui-Rui
    Ghazali, Ahmad-Kamal
    Hara, Yuka
    Aziz, Tengku Nurfarhana Tengku
    Nathan, Sheila
    [J]. MICROBIAL GENOMICS, 2023, 9 (04):
  • [37] Multilocus sequence types of clinical Burkholderia pseudomallei isolates from peninsular Malaysia and their associations with disease outcomes
    Abdel Rahman Zueter
    Zaidah Abdul Rahman
    Mahmoud Abumarzouq
    Azian Harun
    [J]. BMC Infectious Diseases, 18
  • [38] Multilocus sequence types of clinical Burkholderia pseudomallei isolates from peninsular Malaysia and their associations with disease outcomes
    Zueter, Abdel Rahman
    Rahman, Zaidah Abdul
    Abumarzouq, Mahmoud
    Harun, Azian
    [J]. BMC INFECTIOUS DISEASES, 2018, 18
  • [39] Genomic Islands as a Marker to Differentiate between Clinical and Environmental Burkholderia pseudomallei
    Bartpho, Thanatchaporn
    Wongsurawat, Thidathip
    Wongratanacheewin, Surasakdi
    Talaat, Adel M.
    Karoonuthaisiri, Nitsara
    Sermswan, Rasana W.
    [J]. PLOS ONE, 2012, 7 (06):
  • [40] Lipopolysaccharide from nonvirulent Ara+ Burkholderia pseudomallei isolates is immunologically indistinguishable from lipopolysaccharide from virulent Ara- clinical isolates
    Anuntagool, N
    Intachote, P
    Wuthiekanun, V
    White, NJ
    Sirisinha, S
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1998, 5 (02) : 225 - 229